EU-WHO Data Sharing Pact Will 'Positively Benefit' Patients, Says Pharma Industry
This article was originally published in SRA
Executive Summary
A new collaboration between EU drug regulators and the World Health Organization on sharing certain non-public information on the safety, quality and efficacy of medicines that are already authorized or under review has drawn a positive response from the pharmaceutical industry1.